MRUS:Ord/Merus NV - Stock Price Quote and Dividend Data
MRUS STOCK PRICE LATEST CLOSE
$38.62
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Ord/Merus NV Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
Ord/Merus NV Stock Price Information
52-Week Low/High Stock Price$33.19 - $61.61
Percent Held by Institutions96.02%
Revenue$45,273,000
Net Income$-246,249,000
Cash Flow$-252,493,000
EPS-0.41%
Market Cap$2,668,255,800
PE Ratio to Industry40%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.42%
Total Return Last 12 Months-7.47%
Total Return Last 3 Years37.93%
Total Return Last 5 Years219.17%
Latest Trade DateApr. 10, 2025
Ord/Merus NV Annual Stock Dividends
No Data available for Payment History.
Ord/Merus NV Dividend Payment History
| No dividends retrieved for MRUS |
Ord/Merus NV Other Dividend Details
Merus is a clinical-stage oncology company developing antibody therapeutics. Using its Biclonics® platform, Co. has produced and is developing the following candidates: MCLA-128 (zenocutuzumab) for the treatment of solid tumors that harbor Neuregulin 1 gene fusions; MCLA-117 for the treatment of acute myeloid leukemia; MCLA-158 for the treatment of solid tumors; and MCLA-145, developed in collaboration with Incyte Corporation, for the potential treatment of solid tumors and a hematological malignancy, B-cell lymphoma. Co. is also developing a late-stage pre-clinical candidate, MCLA-129 in collaboration with Betta Pharmaceuticals Co. Ltd., for the potential treatment of solid tumors.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Apr. 10, 2025MRUS STOCK PRICE INCREASE: Ord/Merus NV on 04-10-2025 increased stock price > 10% from $34.89 to $39.56
May. 25, 2024MRUS STOCK PRICE INCREASE: Ord/Merus NV on 05-25-2024 increased stock price > 10% from $44.07 to $59.99
Jan. 09, 2024MRUS STOCK PRICE INCREASE: Ord/Merus NV on 01-09-2024 increased stock price > 10% from $28.52 to $33.18
Nov. 04, 2023MRUS STOCK PRICE INCREASE: Ord/Merus NV on 11-04-2023 increased stock price > 10% from $21.94 to $24.88
May. 06, 2023MRUS STOCK PRICE INCREASE: Ord/Merus NV on 05-06-2023 increased stock price > 10% from $18.81 to $20.80
Apr. 19, 2023MRUS STOCK PRICE DECREASE: Ord/Merus NV on 04-19-2023 decreased stock price > 10% from $23.94 to $20.45
Apr. 18, 2023MRUS STOCK PRICE INCREASE: Ord/Merus NV on 04-18-2023 increased stock price > 10% from $21.75 to $23.94
Apr. 15, 2023MRUS STOCK PRICE INCREASE: Ord/Merus NV on 04-15-2023 increased stock price > 10% from $19.52 to $21.75
Feb. 10, 2023MRUS STOCK PRICE INCREASE: Ord/Merus NV on 02-10-2023 increased stock price > 10% from $16.02 to $18.03
Nov. 05, 2022MRUS STOCK PRICE INCREASE: Ord/Merus NV on 11-05-2022 increased stock price > 10% from $15.28 to $17.07
Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00
Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66
Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08
Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06
Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94
Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20
Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12
Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83
Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13
